Fingerprint
Dive into the research topics of 'Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565
Alan P. Venook, Merrill J. Egorin, Gary L. Rosner, Donna Hollis, Sridhar Mani, Michael Hawkins, John Byrd, Raymond Hohl, Daniel Budman, Neal J. Meropol, Mark J. Ratain
Research output: Contribution to journal › Article › peer-review
184
Scopus
citations